Regeneron Pharmaceuticals Inc. (REGN) Online Dividend Calculator
Maximize Returns on Regeneron Pharmaceuticals Inc. (REGN) Investments Using Our Online Dividend Calculator.
Investment Details
About REGN Regeneron Pharmaceuticals Inc.
Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including low-dose Eylea and Eylea HD, approved for wet age-related macular degeneration and other eye diseases; Dupixent in immunology; Praluent for LDL cholesterol lowering; Libtayo in oncology; Kevzara in rheumatoid arthritis; and Lynozyfic for multiple myeloma. Regeneron has multiple partnerships and collaboration agreements, with Sanofi (Dupixent, others) and Bayer (Eylea) as its largest partners.
Top REGN Alternatives with Good High Dividend Stocks
NGG
National Grid Transco PLC National Grid PLC (NEW)
O
Realty Income Corporation
TAK
Takeda Pharmaceutical Company Limited (each representing 1/2 of a share of)
BN
Brookfield Corporation Limited Voting Shares
BKR
Baker Hughes Company
BNS
Bank Nova Scotia Halifax Pfd 3
HLT
Hilton Worldwide Holdings Inc.
COR
Cencora Inc.